Methods of diagnosing a plasmodium infection
US8709741B2 · kind B2 · utility
0Cited by
1References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 3, 2010 |
| Grant date | Apr 29, 2014 |
| Priority date | — |
| Expiry date | Dec 3, 2030 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present disclosure provides in vitro methods of diagnosing a Plasmodium infection in a subject. The methods include measuring the serum concentration of at least one secreted phospholipase A2 selected from the group consisting of GIIF, GV and GX sPLA2s, in a blood sample from the subject. The disclosure also relates to a kit for carrying out the disclosed methods and pharmaceutical compositions comprising a recombinant mammalian GIIF, GV or GX sPLA2, or a combination thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.